Searched for
ZYDUS PHARMACEUTICALS INC
Zydus Lifesciences completes acquisition of AssertioThe company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
Zydus unit recalls 7,248 bottles of Oxybutynin Chloride tablets in USNew Jersey-based Zydus Pharmaceuticals (USA) Inc. is recalling the affected lot due to "Failed Dissolution Specifications", the USFDA state...
Zydus recalls over 55k bottles of generic drug in USUSFDA said the company is recalling the product due to "failed impurities/ degradation specifications". An out-of-specification (OOS) resul...
Dr Reddy's, Zydus Pharma recall products in US marketAs per the report by the USFDA, Zydus Pharmaceuticals (USA) Inc, is recalling 2,880 bottles of Carvedilol tablets, USP 25 mg in the US due ...
Cadila inks pact with Italian firm to launch generic product in USThe partners plan to launch the product which is a generic version of Sanofi Aventis's Lovenox (Enoxaparin Sodium Injection) in seven dosag...
Zydus Pharmaceuticals Inc among cos facing lawsuit by US states: CadilaIn a regulatory filing, Cadila said in its opinion this particular matter is not likely to have any material impact on the operations and f...
Zydus Pharmaceuticals gets USFDA nod for OCD treatment drugThe company has received final approval from the US Food and Drug Administration (USFDA) to market the drug in the strength of 25 mg, 50 mg...
Zydus gets USFDA nod for schizophrenia treatment drugThe company has got final approval from the USFDA to market the drug in the strengths of 25 mg, 50 mg, 100 mg and 200 mg, Zydus Cadila said...
Cadila inks pact with Supernus Pharma to settle patent issueCadila Healthcare have finalised an agreement with Supernus Pharmaceuticals Inc to settle all outstanding patent litigation.
Cadila Healthcare settles patent litigation related to Livalo tabletsThe company and its subsidiary have finalised an agreement with Kowa Company and Nissan Chemical Industries to settle all outstanding paten...
Zydus Pharma Inc recalls 9,504 bottles of Risperidone tabletsRisperidone tablets are used in the treatment of schizophrenia. "The reason for recall is "out of specification for a known degradant," it ...
Zydus gets USFDA nod for morphine sulfate tabletsZydus Group today announced receipt of approval to sell chronic pain reliever morphine sulfate tablets from the US Food and Drug Administra...
Cadila Healthcare recalls 19,536 bottles of cough treatment drug in USDrug firm Cadila is voluntarily recalling 19,536 bottles of benzonatate capsules, used to treat coughs, in the US due to "wet and/or leakin...
Cadila Healthcare recalls 15,144 bottles of hypertension drug in USAs per information available on the USFDA website, Zydus Pharmaceuticals USA Inc, the US-based arm of the company, is recalling the drug du...
Cadila Healthcare recalls blood pressure drug in the USThe recall of the 5,400 bottles has been voluntarily initiated by the company through its US based arm Zydus Pharmaceuticals USA Inc.
Settlement of Somaxon Pharmaceuticals patent suit in US soon: ZydusAhmedabad-based Zydus Cadila says, it agreed to settle a patent litigation suit with US-based Somaxon Pharmaceuticals for insomnia drug – S...
- Zydus Cadila Q1 net up 15.38% at Rs 229.82 crore
Ahmedabad-based Zydus Cadila today said its consolidated net profit rose by 15.38 per cent to Rs 229.82 crore in the first quarter ended Ju...
- Zydus plans to buy US drug cos for $60 mn
Zydus Cadila plans to acquire US-based generic pharma company. The Ahmedabad-based firm signed an asset purchase agreement with a US-based ...
- Zydus forays into generics market of Japan
Cadila Healthcare Ltd on Monday announced the foray of Zydus group into the generic market of Japan and the establishment of a wholly owned...